Losartan May Not Prevent Vestibular Schwannoma Growth or Related Hearing Loss During Observation.
Benjamin D LovinMarc-Elie NaderYun QingMike HernandezShaan RazaFranco DeMontePaul W GidleyPublished in: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2024)
Losartan use may not reduce the risk of VS growth or hearing loss during observation. A randomized trial would be ideal to further identify the true effect on growth and hearing.
Keyphrases